Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
American Financial Group
AFG
$12.1B
| $11M | ﹤0.01% |
79,129
+29,488
| +59% | +$4.15M |
|
2477
PUT
UiPath
PATH
$8.3B
| $11M | ﹤0.01% |
603,400
-625,400
| -51% | -$11.7M |
|
2478
PUT
Global X Lithium & Battery Tech ETF
LIT
$1.61B
| $11M | ﹤0.01% |
151,100
-13,900
| -8% | -$988K |
|
2479
Warner Bros
WBD
$70.2B
| $11M | ﹤0.01% |
817,165
-1,189,291
| -59% | -$22.1M |
|
2480
Vanguard Russell 1000 Value ETF
VONV
$22B
| $11M | ﹤0.01% |
172,538
+163,946
| +1,908% | +$11.3M |
|
2481
Rocket Lab Corp
RKLB
$51.3B
| $11M | ﹤0.01% |
2,891,725
+2,801,057
| +3,089% | +$16.5M |
|
2482
Acadia Realty Trust
AKR
$2.86B
| $11M | ﹤0.01% |
701,469
+379,143
| +118% | +$7.31M |
|
2483
Viavi Solutions
VIAV
$10.7B
| $11M | ﹤0.01% |
827,810
+555,199
| +204% | +$8M |
|
2484
Valvoline
VVV
$4.36B
| $10.9M | ﹤0.01% |
379,389
+372,879
| +5,728% | +$11.5M |
|
2485
CNO Financial Group
CNO
$5.11B
| $10.9M | ﹤0.01% |
604,441
+53,099
| +10% | +$1.14M |
|
2486
Royalty Pharma
RPRX
$26.1B
| $10.9M | ﹤0.01% |
259,845
-1,323,288
| -84% | -$54.2M |
|
2487
WaFd
WAFD
$2.81B
| $10.9M | ﹤0.01% |
363,798
+176,320
| +94% | +$5.54M |
|
2488
PUT
Celsius Holdings
CELH
$7.36B
| $10.9M | ﹤0.01% |
501,000
+234,300
| +88% | +$4.52M |
|
2489
Array Technologies
ARRY
$778M
| $10.9M | ﹤0.01% |
989,700
+202,769
| +26% | +$2M |
|
2490
CALL
Hasbro
HAS
$13.6B
| $10.9M | ﹤0.01% |
132,800
-91,000
| -41% | -$7.88M |
|
2491
Medifast
MED
$128M
| $10.9M | ﹤0.01% |
60,178
+12,742
| +27% | +$2.28M |
|
2492
PUT
Capri Holdings
CPRI
$1.74B
| $10.9M | ﹤0.01% |
264,800
-125,900
| -32% | -$5.86M |
|
2493
CALL
Sprott Uranium Miners ETF
URNM
$2B
| $10.9M | ﹤0.01% |
379,800
+25,200
| +7% | +$893K |
|
2494
Pultegroup
PHM
$24.8B
| $10.8M | ﹤0.01% |
273,400
+203,984
| +294% | +$8.59M |
|
2495
CALL
Range Resources
RRC
$9.42B
| $10.8M | ﹤0.01% |
437,700
+23,000
| +6% | +$704K |
|
2496
Monro
MNRO
$359M
| $10.8M | ﹤0.01% |
252,084
+97,595
| +63% | +$4.36M |
|
2497
CALL
Quanta Services
PWR
$103B
| $10.8M | ﹤0.01% |
86,200
-2,400
| -3% | -$295K |
|
2498
Viridian Therapeutics
VRDN
$2.5B
| $10.8M | ﹤0.01% |
932,299
-8,919
| -0.9% | -$120K |
|
2499
Boston Properties
BXP
$10.9B
| $10.8M | ﹤0.01% |
121,078
+114,182
| +1,656% | +$12.6M |
|
2500
Chewy
CHWY
$9.18B
| $10.8M | ﹤0.01% |
310,134
+72,535
| +31% | +$2.33M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.